Teva plans 'risky' price rise on US medicines | Financial Times
Teva Pharmaceuticals - Wikipedia
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva Recalls U.S.-Made Drugs Following Contamination Fears (3)
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva to cut 14,000 jobs | Business | Chemistry World
There May Be a Silver Lining to Teva's Woes | Ctech
For pharma services firms, big assets can pose major risks
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva, the world's largest generic drugmaker, is cutting 14,000 workers - Los Angeles Times
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva looks to plug gap in its biomanufacturing network
Drugmaker to pay $1.2 billion to settle 'pay for delay' lawsuit | PBS NewsHour
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Israeli drugmaker Teva to cut quarter of global work force | AP News
Teva Canada (@TevaCanadaLtd) / Twitter
Teva Pharmaceuticals - Wikipedia
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News | wvnews.com
Teva halts production at sterile injectables plant to address FDA concerns | FiercePharma
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva CEO says manufacturing cuts will keep coming even after $3B reduction achieved | FiercePharma
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Drugmaker Teva makes $40B bid for rival Mylan
Teva makes first foray into medical cannabis sector, with new distribution deal | The Times of Israel
